Header Logo

Connection

BILL R. BRINKLEY to Cyclin-Dependent Kinase Inhibitor p27

Back to Details
This is a "connection" page, showing publications BILL R. BRINKLEY has written about Cyclin-Dependent Kinase Inhibitor p27.
BILL R. BRINKLEY
Connection Strength
0.011
Cyclin-Dependent Kinase Inhibitor p27
  1. Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFbetaRII. Oncogene. 2000 Jul 27; 19(32):3623-31.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.